# Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques

> **NCT02747173** · — · TERMINATED · sponsor: **Spanish Oncology Genito-Urinary Group** · enrollment: 4 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02747173
- **Lead sponsor:** Spanish Oncology Genito-Urinary Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747173, "Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02747173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*